Loïc Vincent, PhD, is CSO at Affini-T Therapeutics. He is an oncology scientist with 20+ years’ international experience in academia / biotech / pharma industry, dedicated to advancing transformative therapies to patients suffering from cancer. Previously, Loïc was the Head of Takeda Oncology Drug Discovery Unit and Immunology Unit, and was responsible for leading Takeda Cell Therapy Discovery. Prior to joining Takeda in 2016, Loïc spent nine years at Sanofi, where he led Oncology Drug Discovery Pharmacology, Immunotherapy and Oncology External Innovation teams. Loïc is a former board member of the French-American Biotechnology Springboard and former Board Director at Adaptate Biotherapeutics. During his career, Loïc’s teams advanced more than 20 oncology drugs in the clinic.Loïc obtained his PhD in pharmacology from the University of Rouen, France. He carried out his postdoctoral fellowship in oncology at the Weill Medical College of Cornell University, NY.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies